Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens GSK Partnership
Sino Biopharmaceutical will receive $200 million upfront from AstraZeneca, and will be eligible for milestone payments.
----
White House Pressures Top U.S. Grocers on Beef Prices
An Agriculture Department official spoke last week with grocers including Walmart, Kroger and Albertsons, according to people familiar with the matter.
----
GM-Backed Momenta Makes Muted Hong Kong Debut After $751 Million IPO
Shares of the Chinese autonomous driving company rose 2.8% from its IPO price amid caution about the profitability of the self-driving auto industry.
----
Coty to Transfer Gucci Beauty License Back to Kering Ahead of Schedule for $400 Million
In connection with the deal, Kering expects to license out the Gucci beauty brand to L'Oreal starting in mid-2027, which will begin their 50-year exclusive licensing agreement ahead of schedule.
----
SpaceX Shares Stumble in Nasdaq-100 Debut
The rocket maker's stock fell below its first-day opening price amid a broader tech slump.
----
Amazon Taps Bond Market to Raise Money as Borrowing Costs Stay Low
Amazon is returning to the bond market with a multitranche debt offering as strong investor demand keeps borrowing costs low while the company continues investing heavily in AI infrastructure.
----
Why Smucker's $5 Billion Bet on the Twinkie Flopped
Problems arose from the snack's 65-day shelf life as well as changing consumer habits
----
Serta Lenders Win $400 Million Award Over Rival Group's Debt Deal
A bankruptcy judge ordered Serta Simmons Bedding's majority lenders to compensate the minority group over its 2020 liability-management transaction.
----
Nokia's New Act: Supplying the AI Data Center Boom
Shares of the veteran handset maker have surged roughly 90% this year as it pivots to become a heavyweight infrastructure supplier.
----
Beyond the CIA: Palantir Moves Into Mexico's Private Sector
The announcement comes after Palantir Technologies stock fell 25% in June, marking its worst month since February 2021.
----
Rivian's stock sale triggers worst rout for the shares in nearly two years
Rivian's stock falls 18% as Wall Street frets about the EV maker's cash troubles.
----
Democratic Lawmakers Probe Lutnick's Possible Ties to Cantor Fitzgerald Deal
The firm, previously led by the commerce secretary, helped USA Rare Earth raise private funds in connection with the U.S. government's investment.
(END) Dow Jones Newswires
July 08, 2026 03:00 ET (07:00 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments